AzTrials
AzTrials

Cerebral PalsyMOOVNCT04362800

Functional Effects and Impact on Motor Neuronal Activity of Early and Intensive Motrice (Hand and Arm Bimanual Intensive Therapy Including Lower Extremities: HABIT-ILE) Reeducation in Children With Pre-school Bilateral Cerebral Palsy

A study testing MRI, Electro-Encephalography-High Density and 3D and EMG analysis in people with Cerebral Palsy, run by University Hospital, Brest at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

One of the urgent priorities in the field of pediatric neuro-rehabilitation is the development of efficient early motor interventions for children with cerebral palsy (CP). Animal studies suggest that early intensive interventions are likely to have a significant impact on the organization of the brain and… Read more about this study

Who is it for?
Ages 12 to 59 months
Conditions the study is for
Cerebral Palsy
What is being tested?
MRI, Electro-Encephalography-High Density and 3D and EMG analysis
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
36 participants
Where
2 sitesFrance
Study dates
19 Jan 2021to 17 Sep 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 59 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Child with bilateral cerebral palsy proven to be spastic or dyskinetic
  • 1 to 4 years old inclusive (12 to 59 months) (age corrected if premature) able to follow instructions and to be able to carry out all the assessments, in accordance with his age
  • Being matched to a child according to age, etiology of CP / classification of motor function (GMFCS)
  • Signature of consent by the two holders of parental authority

Who cannot join

  • Exceed 4 years and 11 months (59 months) during the internship evaluation period.
  • Uncontrolled epilepsy.
  • History of toxin injection or surgery in the 6 months preceding the study period or scheduled within 3 months (during the study period).
  • Visual or cognitive deficit preventing the child from seeing the games and interacting
  • Usual contraindications to magnetic resonance imaging (MRI) such as metal implants.

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Les Capucins

    Angers, Angers, 49000

  • Fondation ILDYS - Site de Ty Yann

    Brest, Brest, 29000

Other trials in France

About this study

Official title: Functional Effects and Impact on Motor Neuronal Activity of Early and Intensive MOtrice (Hand and Arm Bimanual Intensive Therapy Including Lower Extremities: HABIT-ILE) Reeducation in Children With Pre-school Bilateral Cerebral Palsy: a Trial Multicentre Randomized Control With Medico-economic Evaluation

One of the urgent priorities in the field of pediatric neuro-rehabilitation is the development of efficient early motor interventions for children with cerebral palsy (CP). Animal studies suggest that early intensive interventions are likely to have a significant impact on the organization of the brain and corticospinal tracts, reducing motor impairments and their medium and long-term consequences in children with cerebral palsy. Although most of the growth, development and cortical organization takes place in the time course of the first 2 years of life, most studies investigating the effectiveness of intensive rehabilitation and associated neurophysiological mechanisms have been conducted in school-aged children (> 6 years). In addition, the vast majority of these studies were conducted in children with unilateral CP, while the bilateral form of the pathology has the highest prevalence. It is therefore a priority to investigate the effectiveness of early interventions on the overall motor function of children with CP, especially in children with bilateral form of CP.

Hand and Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) makes it possible to apply the concepts of structured motor learning and intensive treatment to both the upper limbs and the lower limbs and demonstrated improvements at both levels in school-aged children with unilateral CP and bilateral and then at all three International Classification of Functioning and Disability levels. The principles and content of HABIT-ILE can be applied to pre-school children and this method is promising for early neuro-rehabilitation.

Read the detailed description

The main objective of this study is to evaluate the effect of 10 days (i.e. 50 hours) of early HABIT-ILE (HABIT-ILE) on the overall motor function of children aged 1 to 4 with bilateral cerebral palsy in comparison to 10 days (50h) of spontaneous overall motor activity including usual rehabilitation (control group).

Conditions
Cerebral Palsy
Being tested
MRI, Electro-Encephalography-High Density, 3D and EMG analysis, care and classic activities
Keywords
cerebral palsy (CP), pre-school children with bilateral CP
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRIOther

    MRI at baseline and J90

  • Electro-Encephalography-High DensityOther

    Electro-Encephalography-High Density (children with unilateral PC only) at baseline and J90

  • 3D and EMG analysisOther

    3D and EMG analysis at baseline and J90

  • care and classic activitiesOther

    physiotherapy and psychomotility. As needed weekly sessions of speech therapist or orthoptist and daily activities of the child.

Study groups in NCT04362800
Study groupRoleWhat they receive
InterventionalExperimental10 days of intensive and structured motor therapy, 5 hours a day = 50h
Receives: Other: MRI; Other: Electro-Encephalography-High Density; Other: 3D and EMG analysis; Other: care and classic activities
ControlPlacebo comparator10 days of care and classic activities
Receives: Other: MRI; Other: Electro-Encephalography-High Density; Other: 3D and EMG analysis; Other: care and classic activities

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gross Motor Function Measure (GMFM)

    Measures change in gross motor function over time in children with cerebral palsy. The score range from 0 to 100 as a percentage. 100 is the best outcome.

    Measured: 1 hour

Secondary outcomes (8)
  1. Both Hands Assessment

    Assess the extent to which the more severely affected hand can assist during two-handed activities

    Measured: up to 90 days

  2. Melbourne Assessment 2

    Assess the quality of movement in children with neurological disorders

    Measured: up to 90 days

  3. ACTIVLIM-CP

    Assess the child's overall performance during daily activities.

    Measured: up to 90 days

  4. Young Children's Participation and Environment Measure

    Assess the participation of young children with disabilities and delays in terms of patterns of participation at home, in daycare/preschool, and in the community; perceived environmental supports and barriers to participation; and activity-specific parenting strategies to promote participation

    Measured: up to 90 days

  5. Pediatric Evaluation of Disability Inventory Computer Adaptive Test

    assess functional abilities in four areas: activities of daily living, mobility, social/cognitive functioning, and self-care.

    Measured: up to 90 days

  6. Canadian Occupational Performance Measure

    define therapeutic goals and measure the child's progress and the parents' level of satisfaction for each functional goal.

    Measured: up to 90 days

  7. Visual-spatial functions

    Assessment of tracking ability, visual field exploration, and oculomotor coordination using the assessment kit developed by Prof. Chokron of the Adolphe de Rothschild Ophthalmological Foundation in Paris, France

    Measured: up to 90 days

  8. Healthcare Economic Analysis

    to demonstrate the effectiveness of early intensive rehabilitation compared to traditional care through a cost-effectiveness study

    Measured: through study completion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2020
  2. Study start19 Jan 2021
  3. Primary completion17 Sep 2021
  4. Study completion17 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04362800
Sponsor's protocol ID
MOOV (29BRC20.0046)
Acronym
MOOV
Status last verified
May 2026
First submitted
23 Apr 2020
Last updated
7 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected data that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

A study testing MRI, Electro-Encephalography-High Density and 3D and EMG analysis in people with Cerebral Palsy, run by University Hospital, Brest at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gross Motor Function Measure (GMFM) (time frame: 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in